Standard Biotools (LAB) Shares Outstanding (2010 - 2026)

Standard Biotools (LAB) has 17 years of Shares Outstanding data on file, last reported at $390.1 million in Q1 2026.

• Quarterly Shares Outstanding fell 1.89% year-over-year to $390.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $390.1 million (down 1.89% YoY) and the FY2025 annual result came in at $386.4 million, down 2.46% from the prior year.
• Shares Outstanding rose to $390.1 million in Q1 2026 per LAB's latest filing, from $386.4 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $402.2 million in Q3 2025 and bottomed at $26.4 million in Q1 2024.
• The 5-year median for Shares Outstanding is $82.5 million (2023), against an average of $203.5 million.
• The widest annual swing landed in 2024, when Shares Outstanding slumped 68.05%; it then jumped 1425.37% in 2025.
• Tracing LAB's Shares Outstanding over 5 years: stood at $79.9 million in 2022, then climbed by 4.33% to $83.4 million in 2023, then jumped by 375.16% to $396.1 million in 2024, then declined by 2.46% to $386.4 million in 2025, then gained by 0.97% to $390.1 million in 2026.
• Per Business Quant, the three latest LAB Shares Outstanding figures stand at $390.1 million (Q1 2026), $386.4 million (Q4 2025), and $402.2 million (Q3 2025).

Peer Comparison